Qualitek Labs [QLL] vs Sai Life Sciences [SAILIFE] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Qualitek Labs Ltd. wins in 8 metrics, Sai Life Sciences Ltd. wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Qualitek Labs Ltd. | Sai Life Sciences Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 37.58 | 64.75 | Qualitek Labs Ltd. |
| Price-to-Book Ratio | 2.57 | 9.48 | Qualitek Labs Ltd. |
| Debt-to-Equity Ratio | 50.78 | 18.40 | Sai Life Sciences Ltd. |
| PEG Ratio | N/A | 51.15 | N/A |
| EV/EBITDA | 26.91 | 39.40 | Qualitek Labs Ltd. |
| Profit Margin (TTM) | 8.97% | 15.34% | Sai Life Sciences Ltd. |
| Operating Margin (TTM) | 15.25% | 25.84% | Sai Life Sciences Ltd. |
| EBITDA Margin (TTM) | 15.25% | 25.84% | Sai Life Sciences Ltd. |
| Return on Equity | 12.27% | 7.99% | Qualitek Labs Ltd. |
| Return on Assets (TTM) | 7.21% | 5.38% | Qualitek Labs Ltd. |
| Free Cash Flow (TTM) | $-128.53M | $-552.35M | Qualitek Labs Ltd. |
| 1-Year Return | 41.19% | 53.25% | Sai Life Sciences Ltd. |
| Price-to-Sales Ratio (TTM) | 5.12 | 10.00 | Qualitek Labs Ltd. |
| Enterprise Value | $4.38B | $219.67B | Sai Life Sciences Ltd. |
| EV/Revenue Ratio | 6.24 | 10.12 | Qualitek Labs Ltd. |
| Gross Profit Margin (TTM) | N/A | 45.92% | N/A |
| Revenue per Share (TTM) | $79 | $103 | Sai Life Sciences Ltd. |
| Earnings per Share (Diluted) | $9.58 | $15.83 | Sai Life Sciences Ltd. |
| Beta (Stock Volatility) | -0.11 | N/A | N/A |
Qualitek Labs Ltd. vs Sai Life Sciences Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Qualitek Labs Ltd. | -5.64% | -1.91% | 13.33% | 28.71% | 4.29% | 3.82% |
| Sai Life Sciences Ltd. | 0.83% | -1.11% | 4.31% | 13.24% | 28.59% | 25.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Qualitek Labs Ltd. | 41.19% | 147.07% | 147.07% | 147.07% | 147.07% | 147.07% |
| Sai Life Sciences Ltd. | 53.25% | 64.85% | 64.85% | 64.85% | 64.85% | 64.85% |
Performance & Financial Health Analysis: Qualitek Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | QLL | SAILIFE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.59B | ₹217.06B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 8,240 | 509,735 |
| 90 Day Avg. Volume | 7,253 | 545,743 |
| Last Close | ₹385.00 | ₹1,137.70 |
| 52 Week Range | ₹258.55 - ₹458.95 | ₹716.60 - ₹1,184.80 |
| % from 52W High | -16.11% | -3.98% |
| All-Time High | ₹458.95 (Sep 19, 2025) | ₹1,184.80 (May 25, 2026) |
| % from All-Time High | -16.11% | -3.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.27% |
| Quarterly Earnings Growth | N/A | 0.86% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.15% |
| Operating Margin (TTM) | 0.15% | 0.26% |
| Return on Equity (TTM) | 0.12% | 0.08% |
| Debt to Equity (MRQ) | 50.78 | 18.40 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹140.22 | ₹108.17 |
| Cash per Share (MRQ) | ₹0.46 | ₹14.59 |
| Operating Cash Flow (TTM) | ₹104.99M | ₹518.10M |
| Levered Free Cash Flow (TTM) | ₹-329,006,240 | ₹1.70B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Qualitek Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | QLL (Apr 26, 2026) | SAILIFE (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 37.58 | 64.75 |
| Forward P/E | N/A | 51.15 |
| PEG Ratio | N/A | 51.15 |
| Price to Sales (TTM) | 5.12 | 10.00 |
| Price to Book (MRQ) | 2.57 | 9.48 |
| Market Capitalization | ||
| Market Capitalization | ₹3.59B | ₹217.06B |
| Enterprise Value | ₹4.38B | ₹219.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.24 | 10.12 |
| Enterprise to EBITDA | 26.91 | 39.40 |
| Risk & Other Metrics | ||
| Beta | -0.11 | N/A |
| Book Value per Share (MRQ) | ₹140.22 | ₹108.17 |
Financial Statements Comparison: Qualitek Labs Ltd. vs Sai Life Sciences Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | QLL (2025) | SAILIFE (2025) |
|---|---|---|
| Revenue/Sales | 702.27M | 16.60B |
| Cost of Goods Sold | 102.02M | 10.41B |
| COGS % of Revenue | 14.5% | 62.7% |
| Gross Profit | 600.25M | 6.19B |
| Gross Margin | 85.5% | 37.3% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 124.96M | 2.73B |
| Operating Margin | 17.8% | 16.5% |
| EBITDA | 170.94M | 4.46B |
| EBITDA Margin | 24.3% | 26.9% |
| Pre-Tax Income | 104.18M | 2.28B |
| Pre-Tax Income % of Revenue | 14.8% | 13.7% |
| Income Tax | 27.35M | 575.71M |
| Income Tax % of Revenue | 3.9% | 3.5% |
| Net Income (Profit) | 76.84M | 1.70B |
| Profit Margin | 10.9% | 10.2% |
Balance Sheet & Liquidity Metrics
| Metric | QLL (2025) | SAILIFE (2025) |
|---|---|---|
| Cash & Equivalents | 43.10M | 911.19M |
| Total Current Assets | 426.08M | 15.05B |
| Total Current Assets % of Revenue | 60.7% | 90.6% |
| Total Current Liabilities | 325.84M | 7.32B |
| Total Current Liabilities % of Revenue | 46.4% | 44.1% |
| Long-Term Debt | 308.61M | 1.65B |
| Long-Term Debt % of Revenue | 43.9% | 9.9% |
| Total Shareholders Equity | 927.82M | 21.28B |
| Retained Earnings | 145.04M | 7.24B |
| Retained Earnings % of Revenue | 20.7% | 43.6% |
| Property, Plant & Equipment | 589.98M | 1.51B |
Cash Flow Statement Comparison
| Metric | QLL (2025) | SAILIFE (2025) |
|---|---|---|
| Operating Cash Flow | 58.03M | 518.10M |
| Operating Cash Flow % of Revenue | 8.3% | 3.1% |
| Capital Expenditures | -233.17M | -3.69B |
| Free Cash Flow | -128.53M | -552.35M |
| FCF Margin | -18.3% | -3.3% |
| Debt Repayment | N/A | -3.90B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | QLL | SAILIFE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 9.98M | 211.78M |
| Float Shares | 3.60M | 88.67M |
| % Held by Insiders | 65.77% | 38.09% |
| % Held by Institutions | 0.00% | 44.22% |
| % Held by Public | 34.23% | 17.69% |
Dividend Analysis & Yield Comparison: Qualitek Labs Ltd. vs Sai Life Sciences Ltd.
| Metric | QLL | SAILIFE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |